Serina Therapeutics Inc.

About Serina Therapeutics Inc.

Serina Therapeutics is a company driven by relentless curiosity to create life-changing breakthroughs in science. Their focus is on pioneering bold new science for drug delivery and therapeutic solutions.

Products & Services

POZ Platform™:A proprietary technology designed for programmable, targeted delivery of small molecules, enabling safe continuous drug delivery via weekly subcutaneous injections. It is customizable and versatile for various clinical indications, dosed via IV, SC, or IM routes.

Small Molecule Conjugates:A pipeline of wholly-owned CNS drug candidates targeting large markets with significant unmet needs.

RNA Vaccines & Therapeutics:Collaborations to advance LNP-based drug delivery in mRNA immunology, showcasing the broad potential of the POZ platform technology.

Antibody-Drugs (ADCs):POZ technology enables optimized targeting of cancer-killing cytotoxins to potentially improve treatment efficacy.

Specialties

Drug Delivery Technology CNS Drug Development mRNA Immunology Antibody-Drug Conjugates (ADCs) Targeted Cancer Therapies

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Equity Financing T: - FT: Equity Financing	A: 5000000 MR: - FA: $5 million FAN: 5000000	D: 2025-04-08 FD: 2025-04-08	1 investors
2	RT: Equity Financing T: - FT: Equity Financing	A: 5000000 MR: - FA: 5 million FAN: 5000000	D: 2025-02-03 FD: 2025-02-03	1 investors
3	RT: Equity Financing T: - FT: Equity Financing	A: 10000000 MR: - FA: $10 million FAN: 10000000	D: 2024-12-02 FD: 2024-12-02	1 investors

Equity Financing Latest

2025-04-08

$5.0M

1 investor (Pro only)

Equity Financing 2025-02-03

$5.0M

Equity Financing 2024-12-02

$10.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

S

Simba Gill

Executive Chairman

S

Steve Ledger

CEO and Director

R

Randall Moreadith

Chief Development Officer

G

Greg Curhan

CFO

S

Srini Tenjarla

SVP CMC & Formulation

G

Gregory Bailey

Director

View 12 more team members with Pro

Unlock Full Team Directory

Recent News